Washington University School of Medicine: Glioma trials
The registry lists 12 Glioma studies with Washington University School of Medicine as lead sponsor. 2 are open to participants now and 5 have results posted.
Early Phase 1 2Phase 1 4Phase 2 6No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1RecruitingNCT07462507Phase 2
- Window of Opportunity Study of DSP-0390 in GliomasRecruitingNCT06636162Early Phase 1
- rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and TemozolomideActive, not recruitingNCT03687957Phase 1/2Results posted
- Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent GliomasCompletedNCT03532295Phase 2Results posted
- Temozolomide Chronotherapy for High Grade GliomaCompletedNCT02781792Phase 2Results posted
- Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain TumorsTerminatedNCT02372409Phase 2Results posted
- MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant GliomasCompletedNCT02311582Phase 1/2Results posted
- Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant GliomasCompletedNCT05393258Not applicable
- Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State NetworksActive, not recruitingNCT04975139
- Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade GliomasWithdrawnNCT02976441Early Phase 1
- FDOPA-PET/MRI for the Pre-operative Evaluation of GliomasTerminatedNCT02371031Phase 1
- Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS TumorsCompletedNCT01999270Phase 1